In light of (i) previous report highlighting glycosylation as a crucial androgen-regulated process that controls the viability of prostate cancer cells17 and (ii) our recent finding uncovering the reduction of a major subtype of fucosylation in male versus female melanomas16, we sought to assess if AR might transcriptionally control any fucosylation machinery genes. This evidence concerns the gene AR and prostate carcinoma.